Careers Header Bg
Regask Biocommunity Conference 1
REGASK ATTENDS

GTB / JBA / JETRO Bio‑manufacturing Business Matching Meeting

JANUARY 28, 2025 | Tokyo, Japan

Meet our team

Join Natsumi Yamada, Customer Success Manager, as she represents RegASK at the Greater Tokyo Biocommunity (GTB) Bio-manufacturing Business Matching Meeting.

📍 Otemachi Place Hall & Conference, Tokyo, Japan
🗓 Wednesday, January 28, 2026 | 13:00–17:00 (Doors open at 12:00)

Connect with Natsumi Yamada, RegASK’s Customer Success Manager, to learn how AI-driven regulatory intelligence supports bio-manufacturing teams in navigating complex regulatory landscapes, streamlining compliance workflows, and enabling confident, data-informed decisions. Sign up using the form to schedule a time, and we will reach out to connect with you during the event.

Bg Flip Card 1

GTB Bio-manufacturing Business Matching Meeting 2026

The GTB Bio-manufacturing Business Matching Meeting is a networking and business collaboration event focused on advancing the bio-manufacturing sector in Japan.

Organized by the Greater Tokyo Biocommunity (GTB), Japan Bioindustry Association (JBA), and Japan External Trade Organization (JETRO), the event brings together bio-manufacturing professionals, innovators, and industry leaders to explore partnerships, share knowledge, and showcase domestic advancements in bio-manufacturing.

The program features poster sessions, in-person networking opportunities, and collaborative discussions designed to facilitate meaningful business connections and knowledge exchange in the bio-manufacturing space.

Conference Focus Areas Include:

  • Showcasing domestic bio-manufacturing initiatives
  • Facilitating business matchmaking and networking opportunities
  • Sharing innovation in bio-process development and fine chemicals
  • Encouraging collaboration across Tokyo and regional bio-communities

📅 Date & Location

📍 Otemachi Place Hall & Conference, Tokyo, Japan
🗓 Wednesday, January 28, 2026 | 13:00–17:00 (Doors open at 12:00)

What RegASK Brings to GTB Bio-manufacturing Business Matching Meeting

Natsumi Yamada, Customer Success Manager, will be attending the event and is available to meet with attendees who wish to learn more about RegASK. This is an opportunity to discuss AI-driven regulatory intelligence, explore how it supports bio-manufacturing organizations in navigating complex regulatory landscapes, streamlining compliance workflows, and enabling informed, data-driven decision-making.

Our solution

RegASK leverages advanced AI and machine learning to help businesses in highly regulated industries streamline their regulatory compliance processes and stay ahead of the curve. Our cutting-edge solution automates regulatory research, provides vital insights, and empowers regulatory affairs teams to become strategic partners in driving business growth.

Resources

Navigating a Potential U.S. Government Shutdown: Implic…
As legislators in Washington, DC, face a critical March 14th deadline to finalize federal spending, the possibility of a U.S. government shu…
Read more
RegASK Featured in Gartner’s Market Guide for Regulat…
We’re thrilled to share that RegASK has been included in Gartner’s Market Guide for Regulatory Intelligence Solutions! This recognition …
Read more
The 2025 State of Regulatory Affairs and Compliance Rep…
Is your organization prepared for 2025’s regulatory complexities? The regulatory landscape in 2025 is more complex than ever, with new adv…
Read more
ANSM (France) Clarifies CE Mark Exemption Process for M…
On January 27, 2025, the National Security Agency of Medicines and Health Products (ANSM) in France issued a key update regarding the proces…
Read more
US FDA Announces Draft Guidance on AI Use in Regulatory…
On January 6, 2025, the U.S. Food and Drug Administration (FDA) announced the release of a draft guidance titled “Considerations for the U…
Read more
US FDA Announces Public Meeting on Paediatric Legislati…
The Food and Drug Administration (FDA) has scheduled a public meeting titled “Interested Parties Meeting: Implementation of the Best Pharm…
Read more
FDA (USA) Establishes New Center for Real-World Evidenc…
On December 12, 2024, the U.S. Food and Drug Administration (FDA) announced the creation of the Center for Real-World Evidence and Innovatio…
Read more
Portuguese Industry Opposes U.S. Proposal for Cancer Wa…
The United States Health Authority is considering the introduction of mandatory cancer warning labels on alcoholic beverages, a measure simi…
Read more